JPH0439337B2 - - Google Patents
Info
- Publication number
- JPH0439337B2 JPH0439337B2 JP59201362A JP20136284A JPH0439337B2 JP H0439337 B2 JPH0439337 B2 JP H0439337B2 JP 59201362 A JP59201362 A JP 59201362A JP 20136284 A JP20136284 A JP 20136284A JP H0439337 B2 JPH0439337 B2 JP H0439337B2
- Authority
- JP
- Japan
- Prior art keywords
- solid
- tube
- injection
- administration
- semi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007787 solid Substances 0.000 claims description 24
- 238000002347 injection Methods 0.000 claims description 21
- 239000007924 injection Substances 0.000 claims description 21
- 238000009472 formulation Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 230000001681 protective effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 5
- -1 chitin Chemical class 0.000 description 4
- 238000000748 compression moulding Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- DGZSVBBLLGZHSF-UHFFFAOYSA-N 4,4-diethylpiperidine Chemical compound CCC1(CC)CCNCC1 DGZSVBBLLGZHSF-UHFFFAOYSA-N 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 2
- 108010045569 atelocollagen Proteins 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960001196 thiotepa Drugs 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59201362A JPS6179470A (ja) | 1984-09-26 | 1984-09-26 | 固形注射剤または半固形注射剤を内部に保持する製剤投与キツト |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59201362A JPS6179470A (ja) | 1984-09-26 | 1984-09-26 | 固形注射剤または半固形注射剤を内部に保持する製剤投与キツト |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6179470A JPS6179470A (ja) | 1986-04-23 |
| JPH0439337B2 true JPH0439337B2 (es) | 1992-06-29 |
Family
ID=16439792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59201362A Granted JPS6179470A (ja) | 1984-09-26 | 1984-09-26 | 固形注射剤または半固形注射剤を内部に保持する製剤投与キツト |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6179470A (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3802158A1 (de) * | 1987-08-11 | 1989-02-23 | Hoechst Ag | Vorrichtung zur applikation von implantaten |
| ES2028991T3 (es) * | 1987-08-18 | 1992-07-16 | Akzo N.V. | Dispositivo de inyeccion, en concreto para un solo uso, para inyectar un implante debajo de la piel. |
| JPH03251260A (ja) * | 1990-02-28 | 1991-11-08 | Teruo Hoshino | 薬剤注入装置 |
| JPH0460630U (es) * | 1990-09-28 | 1992-05-25 | ||
| GB2437783B (en) * | 2006-04-26 | 2011-11-02 | Summit Medical Ltd | A medical treatment material delivery apparatus |
| JP7355764B2 (ja) * | 2019-02-06 | 2023-10-03 | テルモ株式会社 | 埋込体留置具 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60256467A (ja) * | 1984-05-28 | 1985-12-18 | エス・ミツチエル・ハ−マン | 医療用投薬の方法と手段 |
-
1984
- 1984-09-26 JP JP59201362A patent/JPS6179470A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60256467A (ja) * | 1984-05-28 | 1985-12-18 | エス・ミツチエル・ハ−マン | 医療用投薬の方法と手段 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6179470A (ja) | 1986-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0139286B1 (en) | Prolonged sustained-release preparations | |
| US5021241A (en) | Long-term sustained-release preparation | |
| ES2329346T3 (es) | Composicion de deposito inyectable. | |
| ES2397712T3 (es) | Composiciones farmacéuticas con estabilidad reforzada | |
| KR100483447B1 (ko) | 고체 또는 반-고체의 국부 투입 장치와 비경구적 투약을 위한 서방성 제제와 그 제제의 제조 방법 | |
| EP0436667B1 (en) | Biodegradable in-situ forming implants | |
| US6203813B1 (en) | Pharmaceutical delivery device and method of preparation therefor | |
| EP1484033B1 (en) | Liquid polymeric compositions for controlled release of bioactive substances | |
| US5081156A (en) | Sustained-release preparation | |
| EP0219076A2 (en) | Sustained release composition | |
| ATE318635T1 (de) | Medizinische implantatvorrichtung , einführgerät und implantierungsverfahren für ein wirkstoff und zellen enthaltendes implantat | |
| ATE198979T1 (de) | Zielgerichte verabreichung mittels biologisch abbaubarer polymere | |
| WO2001037896A3 (en) | Methods and compositions for administration of therapeutic reagents | |
| EP0138216B1 (en) | Sustained-release ifn preparation for parenteral administration | |
| ES2217438T3 (es) | Composicion inyectable de polimeros para la produccion de un implante in situ. | |
| AU2005315823B2 (en) | In-situ forming implant for animals | |
| Dunn | The atrigel drug delivery system | |
| US20080299165A1 (en) | Compositions for Treatment of Diseases of the Nail Unit | |
| JPH0439337B2 (es) | ||
| US8987340B2 (en) | Sublimable sustained release delivery system and method of making same | |
| JPH0761959B2 (ja) | シリコンエラストマ−系徐放性製剤 | |
| JPS61236729A (ja) | 徐放性製剤 | |
| RU2756514C1 (ru) | Фармацевтические композиции, имеющие выбранную продолжительность высвобождения | |
| CN214158121U (zh) | 一种长效智能植入式载药装置 | |
| JPS60126217A (ja) | 長期徐放性製剤 |